Psychiatric comorbidity associated with synthetic cannabinoid use compared to cannabis

Association Between Cannabis and Psychosis: Epidemiologic Evidence

(2016) Suzanne H. Gage et al.   BIOLOGICAL PSYCHIATRY

Are cannabidiol and Δ9-tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review

(2015) John M McPartland et al.   BRITISH JOURNAL OF PHARMACOLOGY

Does cannabis affect dopaminergic signaling in the human brain? A systematic review of evidence to date

(2015) Musa Basser Sami et al.   EUROPEAN NEUROPSYCHOPHARMACOLOGY

The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects

(2015) Jan van Amsterdam et al.   JOURNAL OF PSYCHOPHARMACOLOGY

Social Stress and Psychosis Risk: Common Neurochemical Substrates?

(2015) Romina Mizrahi   NEUROPSYCHOPHARMACOLOGY

Neurobiological Interactions Between Stress and the Endocannabinoid System

(2015) Maria Morena et al.   NEUROPSYCHOPHARMACOLOGY

Abnormalities in neuroendocrine stress response in psychosis: the role of endocannabinoids

(2015) E. Appiah-Kusi et al.   PSYCHOLOGICAL MEDICINE

A systematic review of the antipsychotic properties of cannabidiol in humans

(2015) Tabitha A. Iseger et al.   SCHIZOPHRENIA RESEARCH

K2 and Spice use among a cohort of college students in southeast region of the USA

(2015) Kathleen L. Egan et al.   AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE

2013 Annual Report of the American Association of Poison Control Centers’ National Poison Data System (NPDS): 31st Annual Report

(2015) James B. Mowry et al.   CLINICAL TOXICOLOGY

Epidemiological, Neurobiological, and Genetic Clues to the Mechanisms Linking Cannabis Use to Risk for Nonaffective Psychosis

(2014) Ruud van Winkel et al.   Annual Review of Clinical Psychology

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

(2014) Marisol S. Castaneto et al.   DRUG AND ALCOHOL DEPENDENCE

A Multicenter Retrospective Survey of Poisoning after Consumption of Products Containing Synthetic Chemicals in Japan

(2014) Yoshito Kamijo et al.   INTERNAL MEDICINE

Synthetic cannabinoids: Analysis and metabolites

(2014) Mahmoud A. ElSohly et al.   LIFE SCIENCES

Synthetic cannabis: A comparison of patterns of use and effect profile with natural cannabis in a large global sample

(2013) Adam R. Winstock et al.   DRUG AND ALCOHOL DEPENDENCE

“Spiceophrenia”: a systematic overview of “Spice”-related psychopathological issues and a case report

(2013) Duccio Papanti et al.   HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL

A review of clinical manifestations in adolescent and young adults after use of synthetic cannabinoids

(2013) Tracy L. Brewer et al.   Journal for Specialists in Pediatric Nursing

Exposure to Bath Salts and Synthetic Tetrahydrocannabinol from 2009 to 2012 in the United States

(2013) Kelly E. Wood   JOURNAL OF PEDIATRICS

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity?

(2013) William E. Fantegrossi et al.   LIFE SCIENCES

Stress and neurodevelopmental processes in the emergence of psychosis

(2013) C.W. Holtzman et al.   NEUROSCIENCE

Spicing things up: synthetic cannabinoids

(2013) Max Spaderna et al.   PSYCHOPHARMACOLOGY

A Survey of Synthetic Cannabinoid Consumption by Current Cannabis Users

(2013) Erik W. Gunderson et al.   Substance Abuse

Acute toxicity due to the confirmed consumption of synthetic cannabinoids: clinical and laboratory findings

(2012) Maren Hermanns-Clausen et al.   ADDICTION

Synthetic cannabinoid and marijuana exposures reported to poison centers

(2012) MB Forrester et al.   HUMAN & EXPERIMENTAL TOXICOLOGY

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

(2012) Kathryn A. Seely et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

Psychosis Associated With Synthetic Cannabinoid Agonists: A Case Series

(2011) Donald Hurst et al.   AMERICAN JOURNAL OF PSYCHIATRY

Antipsychotic Dose Equivalents and Dose-Years: A Standardized Method for Comparing Exposure to Different Drugs

(2009) Nancy C. Andreasen et al.   BIOLOGICAL PSYCHIATRY

Cannabis and psychosis/schizophrenia: human studies

(2009) Deepak Cyril D’Souza et al.   EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning

(2009) P. D. Morrison et al.   PSYCHOLOGICAL MEDICINE

Cannabinoid self-administration in rats: sex differences and the influence of ovarian function

(2007) L Fattore et al.   BRITISH JOURNAL OF PHARMACOLOGY